Schering-Plough
This article was originally published in The Rose Sheet
Executive Summary
Healthcare products sales dropped 9% in the second quarter due to lower OTC sales because of more competitive markets for vaginal antifungal and cough/cold products, the company stated. Sales of Dr. School's foot care products were down in the quarter as compared to the 1993 period, during which Schering-Plough relaunched the insole line and recorded heavy trade sales. Sun care products "solid" sales growth was boosted by Coppertone Kids and high-SPF products, the firm noted. Sales in the quarter gained 5.9% to $1.19 bil. and, in the half, rose 6.3% to $2.35 bil. Net income in the second quarter jumped 12.9% to $240.7 mil. and leaped 44.2% to $493.9 mil. in the half